The pain felt by many longtime Medtronic Inc. shareholders is turning into a big gain for their favorite charities.
Longtime holders of stock in Fridley's medical technology giant were stunned to learn earlier this year that they'll face potentially large tax bills when Medtronic moves its legal headquarters to Ireland, which is expected to happen early next year. Older shareholders complained directly to Chief Executive Omar Ishrak in August that they didn't have cash to pay the unexpected tax.
For some of them, frustration has since given way to pragmatism. Tax planners and local charities say many longtime holders of stock have decided to offset or even wipe out their Medtronic tax liabilities by donating some or all of their shares to charity. Depending on when and how such donations are made, stock donations can create income tax deductions and reduce or eliminate capital-gains taxes, though individual situations vary widely.
And the charities have figured it out. Some are directly soliciting donations of Medtronic stock, which the company encouraged last week by announcing it would match up to $1 million in stock donations to Greater Twin Cities United Way. Meanwhile the Minneapolis Foundation is promoting the creation of donor-advised funds with Medtronic shares, which would allow donors to see immediate tax deductions while spreading out the giving over future years.
"To people who have the means to do a large charitable contribution, this is by far the best answer they're going to get on this," said David Brauer, head of the tax department at Minneapolis tax accounting firm Lurie Besikof Lapidus & Co. "For those not in a position to do a large charitable donation, they're left with selling some of the stock to fund the tax, most likely."
For those who do donate stock, timing can be critical.
In order to wipe out the 30 percent tax on the gain in value of Medtronic stock, a donor would have to give it to charity before the company closes its proposed deal. Medtronic is planning to execute the biggest merger in its history, acquiring Dublin-based health care supplier Covidien for $42.9 million stock and debt, and then moving the combined company under a corporate parent based in Ireland, where business taxes are about a third of the U.S. rate of 35 percent.
The deal would be taxable for shareholders because they would in effect be exchanging their shares in the current Medtronic for an equal amount of stock in the new company, called Medtronic PLC.